Identity
HGNC
LOCATION
6p25.3
LOCUSID
ALIAS
JKAP,JSP-1,JSP1,LMW-DSP2,LMWDSP2,MKP-x,MKPX,VHX
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 56940
MIM: 616778
HGNC: 16077
Ensembl: ENSG00000112679
Variants:
dbSNP: 56940
ClinVar: 56940
TCGA: ENSG00000112679
COSMIC: DUSP22
RNA/Proteins
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37937915 | 2024 | DUSP22 suppresses tumor progression by directly dephosphorylating AKT in non-small cell lung cancer. | 0 |
| 38225265 | 2024 | The phosphatase DUSP22 inhibits UBR2-mediated K63-ubiquitination and activation of Lck downstream of TCR signalling. | 1 |
| 38495810 | 2024 | DUSP22 Ameliorates Endothelial-to-Mesenchymal Transition in HUVECs through Smad2/3 and MAPK Signaling Pathways. | 0 |
| 38851418 | 2024 | Exosomal miR-1228-5p down-regulates DUSP22 to promotes cell proliferation and migration in small cell lung cancer. | 0 |
| 37937915 | 2024 | DUSP22 suppresses tumor progression by directly dephosphorylating AKT in non-small cell lung cancer. | 0 |
| 38225265 | 2024 | The phosphatase DUSP22 inhibits UBR2-mediated K63-ubiquitination and activation of Lck downstream of TCR signalling. | 1 |
| 38495810 | 2024 | DUSP22 Ameliorates Endothelial-to-Mesenchymal Transition in HUVECs through Smad2/3 and MAPK Signaling Pathways. | 0 |
| 38851418 | 2024 | Exosomal miR-1228-5p down-regulates DUSP22 to promotes cell proliferation and migration in small cell lung cancer. | 0 |
| 36453104 | 2023 | DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. | 6 |
| 36453105 | 2023 | ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study. | 6 |
| 36453106 | 2023 | DUSP22-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome. | 5 |
| 36765305 | 2023 | Dual-specificity phosphatases 22-deficient T cells contribute to the pathogenesis of ankylosing spondylitis. | 3 |
| 38179996 | 2023 | Serum JKAP reflects Th2 and Th17 cell levels, and diabetic nephropathy risk and severity in diabetes mellitus patients. | 0 |
| 36453104 | 2023 | DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. | 6 |
| 36453105 | 2023 | ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study. | 6 |
Citation
Dessen P
DUSP22 (dual specificity phosphatase 22)
Atlas Genet Cytogenet Oncol Haematol. 2003-06-01
Online version: http://atlasgeneticsoncology.org/gene/40373/dusp22
